COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug fix clotting problems in sepsis? new trial aims to find out
Disease control Not yet recruitingThis study tests a drug called sivelestat in 120 adults with septic shock and blood clotting problems. The drug aims to help the body break down small blood clots that form during sepsis. Researchers will measure changes in a key clotting protein after 24 hours of treatment.
Matched conditions: COAGULOPATHY
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 03, 2026 09:05 UTC
-
AI takes on blood clot experts in new study
Knowledge-focused Not yet recruitingThis study will check if artificial intelligence (AI) can interpret ROTEM blood clotting tests as accurately as expert doctors. ROTEM is used to guide treatment for bleeding in surgery or critical illness, but its interpretation can vary between experts. Researchers will compare …
Matched conditions: COAGULOPATHY
Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC